HomeCompareIVMED vs FCPT

IVMED vs FCPT: Dividend Comparison 2026

IVMED yields 285714.29% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IVMED wins by $1.734986541242196e+31M in total portfolio value
10 years
IVMED
IVMED
● Live price
285714.29%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.734986541242196e+31M
Annual income
$17,337,928,197,276,910,000,000,000,000,000,000,000.00
Full IVMED calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — IVMED vs FCPT

📍 IVMED pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIVMEDFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IVMED + FCPT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IVMED pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IVMED
Annual income on $10K today (after 15% tax)
$24,285,714.29/yr
After 10yr DRIP, annual income (after tax)
$14,737,238,967,685,373,000,000,000,000,000,000,000.00/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, IVMED beats the other by $14,737,238,967,685,373,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IVMED + FCPT for your $10,000?

IVMED: 50%FCPT: 50%
100% FCPT50/50100% IVMED
Portfolio after 10yr
$8.67493270621098e+30M
Annual income
$8,668,964,098,638,455,000,000,000,000,000,000,000.00/yr
Blended yield
99.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

IVMED
No analyst data
Altman Z
-205.3
Piotroski
2/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IVMED buys
0
FCPT buys
0
No recent congressional trades found for IVMED or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIVMEDFCPT
Forward yield285714.29%6.05%
Annual dividend / share$2.00$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$1.734986541242196e+31M$49.1K
Annual income after 10y$17,337,928,197,276,910,000,000,000,000,000,000,000.00$5,775.28
Total dividends collected$1.734908400352195e+31M$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: IVMED vs FCPT ($10,000, DRIP)

YearIVMED PortfolioIVMED Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$28,582,129$28,571,428.57$11,401$700.92+$28.57MIVMED
2$76,351,353,429$76,320,770,551.21$13,064$864.84+$76351.34MIVMED
3$190,619,493,207,524$190,537,797,259,355.30$15,051$1,072.48+$190619493.19MIVMED
4$444,781,927,427,195,200$444,577,964,569,463,100.00$17,442$1,337.22+$444781927427.18MIVMED
5$969,967,353,346,567,200,000$969,491,436,684,220,000,000.00$20,340$1,677.08+$969967353346567.13MIVMED
6$1,976,961,629,315,093,000,000,000$1,975,923,764,247,012,300,000,000.00$23,880$2,116.57+$1976961629315092992.00MIVMED
7$3,765,923,944,594,039,000,000,000,000$3,763,808,595,650,671,000,000,000,000.00$28,241$2,689.36+$3.765923944594039e+21MIVMED
8$6,704,681,437,057,684,000,000,000,000,000$6,700,651,898,436,968,000,000,000,000,000.00$33,660$3,442.07+$6.704681437057683e+24MIVMED
9$11,156,275,836,497,016,000,000,000,000,000,000$11,149,101,827,359,364,000,000,000,000,000,000.00$40,456$4,439.95+$1.1156275836497015e+28MIVMED
10$17,349,865,412,421,960,000,000,000,000,000,000,000$17,337,928,197,276,910,000,000,000,000,000,000,000.00$49,063$5,775.28+$1.734986541242196e+31MIVMED

IVMED vs FCPT: Complete Analysis 2026

IVMEDStock

Whitebeard Inc., a development stage company, engages in the research and development of medical devices with `near-patient' testing applications. Its primary product includes prothrombin monitor, which is used for the measurement of coagulation of blood in patients at risk of heart disease and stroke. The company's other products under development include predictor of labor onset, a consumer device for maternity planning; biomarker monitor for the measurement of a number of biomarkers, including heart attack, HIV, cholesterol, and cancer; blood glucose monitor, a noninvasive glucose concentration continuous bulk measuring device measurement; digital scanning machine, a noninvasive alternative to 2D X-ray scanning; osteoporosis detection and monitoring device, an instant display of bonemineral density for osteoporosis patients; and hand held digital strip reader for immunoassay applications. It was formerly known as In Vivo Medical Diagnostics, Inc. and changed its name to In Veritas Medical Diagnostics, Inc. in 2005. The company is based in Inverness, the United Kingdom.

Full IVMED Calculator →

FCPTREIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this IVMED vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IVMED vs SCHDIVMED vs JEPIIVMED vs OIVMED vs KOIVMED vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.